|
|
|
|
|
|
|
Of note are recent findings that women who have no vasomotor symptoms when they begin HRT do not develop such symptoms when treatment is first instituted and then abruptly stopped after 3 months. This may be useful information for a clinician to provide a patient who is undecided about whether to begin HRT when she is not experiencing vasomotor symptoms.
For the past 50 years, conjugated equine
estrogen, brand name Premarin® has been the most commonly prescribed estrogen
supplement in the U.S. Conjugated estrogens are derived from pregnant mare's
urine.
One
of the most effective herbal products available today, Imperial Gold
So which is natural? Is natural better? If so why?
It all depends on what YOU consider natural, remember, there are many
"natural" poisons. If you consider "natural", that which
occurs in the body in the highest concentration after menopause, then estrone is
the natural estrogen for you. Estrone is easy to get. Most of the prescription
estrogens when taken by mouth are converted in your GI tract and end up
predominantly as estrone.
|
| PLANT BASED | |||||
| Drug Name or Herb | Route | Years | FDA Approved
or Herbal Requiring No FDA Approval |
Strength | Cost/Day* |
| Alora® | Transdermal | 1 | Menopausal Syndrome | 0.05 mg 0.075 mg 0.1 mg |
0.72 0.72 0.72 |
| Cenestin® | Oral | 1 | Menopausal Syndrome | 0.625 mg 0.9 mg |
0.37 0.37 |
| Climara® | Transdermal | 1 | Menopausal Syndrome | 0.05 mg 0.75 mg 0.1 mg |
0.72 0.72 0.72 |
| Estrace® | Oral Vaginal |
20 10 |
Menopausal
Syndrome Osteoporosis Vaginal Atrophy |
0.5 mg 1.0 mg 2.0 mg 0.1% cream |
0.31 0.38 0.56 1.61 |
| Estroderm® | Transdermal | 10 | Menopausal
Syndrome Osteoporosis |
0.05 mg 0.1 mg |
0.72 0.80 |
| Estratab® | Oral | 20 | Menopausal Syndrome Osteoporosis |
0.3 mg 0.625 mg 1.25 mg 2.5 mg |
0.32 0.32 0.32 0.32 |
| Estring® | Vaginal Ring | 1 | Vaginal Atrophy | 5-10 mg | |
| FemPatch® | Transdermal | 1 | Menopausal Syndrome | 0.05 mg 0.1 mg |
0.72 0.72 |
| Imperial
Gold Maca™
|
Oral | 100+ | Menopausal
Syndrome Osteoporosis Vaginal Atrophy Fatigue Fertility Aphrodisiac Mental Clarity |
600
mg Suggested 6 Daily For First Week For Maximum Results. |
0.20 |
| Menest® | Oral | 20 | Menopausal Syndrome | 0.3 mg 0.625 mg 1.25 mg 2.5 mg |
0.32 0.32 0.32 0.32 |
| Ogen® | Oral | 40 | Menopausal Syndrome Osteoporosis |
0.625 mg 1.25 |
0.58 0.77 |
| Ortho-est® | Oral | 2 | Menopausal Syndrome | 0.625 mg 1.25 mg |
0.58 0.77 |
| Vivelle® | Transdermal | 1 | Menopausal Syndrome | 0.037 mg 0.05 0.75 0.1 |
0.72 0.72 0.72 0.72 |
| ANIMAL BASED | |||||
| Drug Name | Route | Years | FDA Approved for | Strength | Cost/Day* |
| Premarin® | Oral | 50 | Menopausal Syndrome Osteoporosis |
0.3 mg 0.625 mg 0.9 mg 1.25 mg 2.5 mg |
0.37 0.37 0.37 0.37 0.37 |
| ESTROGEN/PROGESTERONE COMBINATIONS | |||||
| Drug Name | Route | Years | FDA Approved for | Strength | Cost/day* |
| CombiPatch® | Transdermal | 1 | Menopausal Syndrome | 0.05 mg estradiol 0.14 mg norethindrone |
0.72 |
| femhrt® | Oral | 1 | Menopausal Syndrome Osteoporosis |
5 mcg ethinyl estradiol 1 mg norethindrone continous |
0.73 |
| Ortho-Prefest® | Oral | 1 | Menopausal Syndrome Osteoporosis |
1 mg estradiol 0.09 mg norgestimate sequential |
0.73 |
| Prempro® | Oral | 5 | Menopausal Syndrome Osteoporosis |
0.625 mg premarin 2.5 mg cycrin continous |
0.73 |
| Premphase® | Oral | 5 | Menopausal Syndrome Osteoporosis |
0.625 mg premarin 5 mg cycrin sequential |
0.73 |
| ESTROGEN - ANDROGEN COMBINATIONS | |||||
| Drug Name | Route | Years | FDA Approved for | Strength | Cost/Day* |
| Estratest® | Oral | 5 | Menopausal Syndrome Osteoporosis |
1.25/2.5 mg | 0.90 |
| Estratest HS® | Oral | 5 | Menopausal Syndrome Osteoporosis |
0.625/1.25 mg | 0.74 |
|
|
|
|